Home > Balance Sheet > GLAND PHARMA

GLAND PHARMA
Net Current Assets

    Back to Balance Sheet
GLAND PHARMA is part of below Screeners ↓
Top Mid Cap Stocks with Best Fundamentals
Best 1M Momentum Mid Cap Stocks
COMMUNITY POLL
for GLAND PHARMA
Please provide your vote to see the results

GLAND PHARMA Last 5 Year Net Current Assets History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023Mar2022
Net Current Assets (Including Current Investments) ₹5,918 Cr₹5,218 Cr₹4,247 Cr₹6,172 Cr₹5,270 Cr

What is the latest Net Current Assets ratio of GLAND PHARMA ?

The latest Net Current Assets ratio of GLAND PHARMA is ₹5,918 Cr based on Mar2026 Consolidated results.
Year Net Current Assets
Mar2026₹5,918 Cr
Mar2025₹5,218 Cr
Mar2024₹4,247 Cr
Mar2023₹6,172 Cr
Mar2022₹5,270 Cr

How is Net Current Assets of GLAND PHARMA Trending?

Years Net Current Assets % Change
Mar2026 ₹5,918 Cr
13.42
Mar2025 ₹5,218 Cr
22.87
Mar2024 ₹4,247 Cr
-31.19
Mar2023 ₹6,172 Cr
17.11
Mar2022 ₹5,270 Cr -

Compare Net Current Assets of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹54,967.3 Cr -1.4% 16.5% 81.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹452,299.0 Cr 1% 7.5% 7.9% Stock Analytics
DIVIS LABORATORIES ₹297,325.0 Cr 0.8% 22.8% 71.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹178,727.0 Cr 0.2% 1.9% 20.9% Stock Analytics
DR REDDYS LABORATORIES ₹116,145.0 Cr 0.8% 12.2% 12.3% Stock Analytics
CIPLA ₹114,312.0 Cr 1.5% 6.4% -7.8% Stock Analytics


GLAND PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-1.4%

16.5%

81.4%

SENSEX

2.9%

13.9%

-0.8%


You may also like the below Video Courses